LYST expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.715400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.248200E-01
Normal-vs-Stage2
5.746600E-01
Normal-vs-Stage3
6.056000E-01
Normal-vs-Stage4
7.261400E-01
Stage1-vs-Stage2
6.451600E-01
Stage1-vs-Stage3
8.534000E-01
Stage1-vs-Stage4
4.144600E-01
Stage2-vs-Stage3
8.492000E-01
Stage2-vs-Stage4
2.720200E-01
Stage3-vs-Stage4
4.453800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.730400E-01
Normal-vs-AfricanAmerican
5.387400E-01
Normal-vs-Asian
5.173400E-01
Caucasian-vs-AfricanAmerican
6.903000E-01
Caucasian-vs-Asian
4.068800E-01
AfricanAmerican-vs-Asian
8.372600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.666600E-01
Normal-vs-Female
5.780800E-01
Male-vs-Female
7.513200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.937600E-01
Normal-vs-Age(41-60Yrs)
6.163800E-01
Normal-vs-Age(61-80Yrs)
5.537800E-01
Normal-vs-Age(81-100Yrs)
5.298800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.720200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.864000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.633600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.281390E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.747500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.725800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.536000E-01
Normal-vs-Daily Drinker
5.031000E-01
Normal-vs-Weekly Drinker
5.464200E-01
Normal-vs-Occasional Drinker
6.256000E-01
Normal-vs-Social Drinker
5.890600E-01
Non Drinker-vs-Daily Drinker
3.643000E-01
Non Drinker-vs-Weekly Drinker
9.019000E-01
Non Drinker-vs-Occasional Drinker
2.588000E-01
Non Drinker-vs-Social Drinker
7.158400E-01
Daily Drinker-vs-Weekly Drinker
5.535600E-01
Daily Drinker-vs-Occasional Drinker
3.168000E-02
Daily Drinker-vs-Social Drinker
3.897400E-01
Weekly Drinker-vs-Occasional Drinker
2.996400E-01
Weekly Drinker-vs-Social Drinker
7.215200E-01
Occasional Drinker-vs-Social Drinker
6.961200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.281800E-01
Normal-vs-Grade 2
2.239900E-02
Normal-vs-Grade 3
4.794100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.324100E-02
Grade 1-vs-Grade 3
2.548600E-01
Grade 1-vs-Grade 4
2.281800E-01
Grade 2-vs-Grade 3
2.158200E-01
Grade 2-vs-Grade 4
2.239900E-02
Grade 3-vs-Grade 4
4.794100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.588200E-01
Normal-vs-NonDiabetic
5.520600E-01
Diabetic-vs-NonDiabetic
8.828600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.576600E-01
Normal-vs-NoPancreatitis
5.605400E-01
Pancreatitis-vs-NoPancreatitis
9.489600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.096200E-01
Normal-vs-N1
5.575600E-01
N0-vs-N1
2.041800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.712200E-01
Normal-vs-TP53-NonMutant
5.562000E-01
TP53-Mutant-vs-TP53-NonMutant
7.663000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
